Diversification via an ETF can help biotech investors avoid boom-or-bust volatility while still capitalizing on long-term growth trends.

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

XPH delivered 19% higher returns over five years despite half the volatility. XBI's 165 holdings offer broader exposure but ...

The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index.

Biotech firms have been increasingly directing capital toward oncology therapeutics in recent years, reflecting a structural shift as companies recognize the significant commercial potential of ...

The biotech sector is heading into the third-quarter earnings season with a tug-of-war between higher interest rates and an ...

A 100% tariff on imported drugs just expanded to cover every drugmaker in the country, yet the biotech market's most closely ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Scientists meticulously analyze complex data on a monitor ...

In addition to the reversion trade factors, the sector has benefited from the steady move down in interest rates in 2025. This has been a tailwind for higher beta areas of the small caps, like small ...

The investment seeks to provide long-term capital appreciation. The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of ...

Vanguard Health Care ETF offers a significantly lower expense ratio and higher dividend yield than iShares Biotechnology ETF. iShares' ETF has delivered stronger one-year total returns but carries ...

Get the live BBC stock price and quote for the Virtus LifeSci Biotech Clinical Trials ETF ETF, plus charts, share price, forecast and historical data.